LPL Financial
SLS icon

LPL Financial’s SELLAS Life Sciences SLS Stock Holding History

LPL Financial’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,000
Closed -$41.5K – 6142
2025
Q4 		$41.5K Buy
+11,000
New +$21.4K ﹤0.01% 5723

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

LPL Financial's SLS Position: Q2 2026 in Review

LPL Financial increased its SELLAS Life Sciences (SLS) stake by 13% in Q2 2026, buying an estimated $127K and bringing the position to 155,663 shares worth $2.3M. The position accounts for ﹤0.01% of the portfolio, ranked #3606.

LPL Financial first reported a position in SLS in Q2 2024 and has held it in 9 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • LPL Financial held 155,663 shares of SELLAS Life Sciences worth $2.3M as of Q2 2026.
  • LPL Financial bought 18,455 SELLAS Life Sciences shares in Q2 2026, an estimated $127K.
  • SELLAS Life Sciences made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #3606 holding.
  • LPL Financial first reported a position in SELLAS Life Sciences in Q2 2024 and has held it in 9 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.